Pyruvate kinase M2 contributes to cell growth in gastric cancer via aerobic glycolysis.

In conclusion, the results of this study indicated that inhibition of PKM2 could represent a novel strategy for gastric cancer treatment.
PMID: 31000383 [PubMed - as supplied by publisher]

Source: Pathology, Research and Practice - April 6, 2019 Category: Pathology Authors: Li H, Xu H, Xing R, Pan Y, Li W, Cui J, Lu Y Tags: Pathol Res Pract Source Type: research